mRNA |
BRD-K03536150 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
4e-07 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
1e-05 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
3e-05 |
mRNA |
ouabain |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
4e-05 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
4e-05 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
6e-05 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0002 |
mRNA |
AZD0530 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0002 |
mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
0.37 |
0.0002 |
mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0003 |